134 related articles for article (PubMed ID: 9081762)
1. Putative periodontal pathogens, antibody titres and avidities to them in a longitudinal study of patients with resistant periodontitis.
Holbrook WP; Mooney J; Sigurdsson T; Kitsiou N; Kinane DF
Oral Dis; 1996 Sep; 2(3):217-23. PubMed ID: 9081762
[TBL] [Abstract][Full Text] [Related]
2. Serum IgG antibody response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis: implications for periodontal diagnosis.
Lamster IB; Kaluszhner-Shapira I; Herrera-Abreu M; Sinha R; Grbic JT
J Clin Periodontol; 1998 Jun; 25(6):510-6. PubMed ID: 9667485
[TBL] [Abstract][Full Text] [Related]
3. Humoral immune responses to Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans in adult periodontitis and rapidly progressive periodontitis.
Mooney J; Kinane DF
Oral Microbiol Immunol; 1994 Dec; 9(6):321-6. PubMed ID: 7870466
[TBL] [Abstract][Full Text] [Related]
4. Relative avidity of serum antibodies to putative periodontopathogens in periodontal disease.
Mooney J; Adonogianaki E; Kinane DF
J Periodontal Res; 1993 Nov; 28(6 Pt 1):444-50. PubMed ID: 8254462
[TBL] [Abstract][Full Text] [Related]
5. Local and systemic antibody response to putative periodontopathogens in patients with chronic periodontitis: correlation with clinical indices.
Kinane DF; Mooney J; MacFarlane TW; McDonald M
Oral Microbiol Immunol; 1993 Apr; 8(2):65-8. PubMed ID: 8395040
[TBL] [Abstract][Full Text] [Related]
6. Additional clinical and microbiological effects of amoxicillin and metronidazole after initial periodontal therapy.
Winkel EG; van Winkelhoff AJ; van der Velden U
J Clin Periodontol; 1998 Nov; 25(11 Pt 1):857-64. PubMed ID: 9846793
[TBL] [Abstract][Full Text] [Related]
7. Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double-blind placebo-controlled study.
Winkel EG; Van Winkelhoff AJ; Timmerman MF; Van der Velden U; Van der Weijden GA
J Clin Periodontol; 2001 Apr; 28(4):296-305. PubMed ID: 11314884
[TBL] [Abstract][Full Text] [Related]
8. Cell envelope and cell wall immunization of Macaca fascicularis: effect on the progression of ligature-induced periodontitis.
Holt SC; Brunsvold M; Jones A; Wood R; Ebersole JL
Oral Microbiol Immunol; 1995 Dec; 10(6):321-33. PubMed ID: 8602339
[TBL] [Abstract][Full Text] [Related]
9. Differential clinical treatment outcome after systemic metronidazole and amoxicillin in patients harboring Actinobacillus actinomycetemcomitans and/or Porphyromonas gingivalis.
Flemmig TF; Milián E; Karch H; Klaiber B
J Clin Periodontol; 1998 May; 25(5):380-7. PubMed ID: 9650874
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal changes in antibody avidity to Actinobacillus actinomycetemcomitans in periodontitis.
O'Dell DS; Ebersole JL
J Clin Periodontol; 1996 Mar; 23(3 Pt 1):203-11. PubMed ID: 8707979
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of systemic metronidazole and amoxicillin on Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in intraoral habitats.
Flemmig TF; Milián E; Kopp C; Karch H; Klaiber B
J Clin Periodontol; 1998 Jan; 25(1):1-10. PubMed ID: 9477013
[TBL] [Abstract][Full Text] [Related]
12. Humoral immune response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in periodontal disease.
Kinane DF; Mooney J; Ebersole JL
Periodontol 2000; 1999 Jun; 20():289-340. PubMed ID: 10522229
[No Abstract] [Full Text] [Related]
13. Salivary levels of suspected periodontal pathogens in relation to periodontal status and treatment.
von Troil-Lindén B; Torkko H; Alaluusua S; Jousimies-Somer H; Asikainen S
J Dent Res; 1995 Nov; 74(11):1789-95. PubMed ID: 8530742
[TBL] [Abstract][Full Text] [Related]
14. Relationship between serum antibody titres to Porphyromonas gingivalis and hs-CRP levels as inflammatory markers of periodontitis.
Miyashita H; Honda T; Maekawa T; Takahashi N; Aoki Y; Nakajima T; Tabeta K; Yamazaki K
Arch Oral Biol; 2012 Jun; 57(6):820-9. PubMed ID: 22172404
[TBL] [Abstract][Full Text] [Related]
15. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis subgingival presence, species-specific serum immunoglobulin G antibody levels, and periodontitis disease recurrence.
Rams TE; Listgarten MA; Slots J
J Periodontal Res; 2006 Jun; 41(3):228-34. PubMed ID: 16677293
[TBL] [Abstract][Full Text] [Related]
16. Porphyromonas gingivalis, Bacteroides forsythus and other putative periodontal pathogens in subjects with and without periodontal destruction.
van Winkelhoff AJ; Loos BG; van der Reijden WA; van der Velden U
J Clin Periodontol; 2002 Nov; 29(11):1023-8. PubMed ID: 12472995
[TBL] [Abstract][Full Text] [Related]
17. The use of metronidazole and amoxicillin in the treatment of advanced periodontal disease. A prospective, controlled clinical trial.
Berglundh T; Krok L; Liljenberg B; Westfelt E; Serino G; Lindhe J
J Clin Periodontol; 1998 May; 25(5):354-62. PubMed ID: 9650870
[TBL] [Abstract][Full Text] [Related]
18. Clinical and microbiological effects of different antimicrobials on generalized aggressive periodontitis.
Xajigeorgiou C; Sakellari D; Slini T; Baka A; Konstantinidis A
J Clin Periodontol; 2006 Apr; 33(4):254-64. PubMed ID: 16553634
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to periodontal pathogens and stroke risk.
Pussinen PJ; Alfthan G; Rissanen H; Reunanen A; Asikainen S; Knekt P
Stroke; 2004 Sep; 35(9):2020-3. PubMed ID: 15232116
[TBL] [Abstract][Full Text] [Related]
20. Patterns of antibody response in subjects with periodontitis.
Haffajee AD; Socransky SS; Taubman MA; Sioson J; Smith DJ
Oral Microbiol Immunol; 1995 Jun; 10(3):129-37. PubMed ID: 7567061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
